Intravenous Immunoglobulin (IVIg) Market With Geographic Segmentation, Statistical Forecast and Competitive Analysis Report
Market research future has a half-cooked research report on Global Intravenous Immunoglobulin (IVIg) Market. The global market for Intravenous Immunoglobulin (IVIg) market is growing continuously and expected to grow at a CAGR of 5.9% from 2016 to 2023. Taste the market data and market information presented through more than 64 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Intravenous Immunoglobulin (IVIg) Market Research Report –Global Forecast to 2023.”
The global Intravenous Immunoglobulin (IVIg) market has
been evaluated as moderately growing market and it is expected that the market
will continue to grow similarly soon. The demand for new products and therapy
is growing continuously. The market for Intravenous Immunoglobulin (IVIg) was
around US$ 5910.8 million in 2016 and is expected to grow at a CAGR of 5.9% by
2023.
https://www.marketresearchfuture.com/sample_request/3137
Major Players in Intravenous Immunoglobulin (IVIg) market:
There are plenty of large and small market players which
operate in this market: ABEONA THERAPEUTICS (US), Baxter (US), BDI Pharma (US),
Biotest AG.(Germany),, China Biologic Products, Inc. (China), CSL Behring (US),
Grifols Inc. (Spain), Kedrion S.p.A (us), Octapharma (Switzerland), Shire
(Republic of Ireland), AND others.
Considering the global scenario of the market, North
America was holding largest market share in global IVIg market in 2016. While
the European market, especially Western Europe is growing and second largest
market for Global IVIg. Asia-Pacific will be fastest growing market for IVIg
during the forecasted period. Middle East and Africa is expected to grow at
steady pace during the forecast period.
Intravenous
Immunoglobulin (IVIg) Market has been segmented on the basis of type which
comprise Plaque psoriasis, Scalp psoriasis, Nail psoriasis, Guttate psoriasis,
Inverse psoriasis, Pustular psoriasis, Erythrodermic psoriasis and others.
Plaque psoriasis is most common type and about 80% of the cases are plaque
psoriasis. On the basis of treatment
type it segmented into Topical corticosteroids, Vitamin D analogues
(Calcipotriene, Calcitriol), Anthralin, Topical retinoids (Retinol, Tretinoin
(retinoic acid / retin-A /Steiva-A), Adapalene (Differin), Tazarotene),
Calcineurin inhibitors (tacrolimus (Prograf), pimecrolimus (Elidel)), Salicylic
acid, Coal tar, Moisturizers, and Others. Vitamin D analogs such as
Calcipotriene and Calcitriol very helpful and helps to slow skin cell growth.
Topical retinoids like are Retinol, Tretinoin (retinoic acid / retin-A
/Steiva-A), Adapalene (Differin), Tazarotene are vitamin A derivatives that
helps to reduce inflammation.
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment